Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound, and biomarker assessments.

Details

Language :

English

ISSN :

00257974

Volume :

99

Issue :

30

Database :

Complementary Index

Journal :

Medicine

Publication Type :

Academic Journal

Accession number :

145334742

Full Text :

https://doi.org/10.1097/MD.0000000000021151